Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Tibsovo
.
Show all posts
Showing posts with label
Tibsovo
.
Show all posts
Saturday, June 29, 2019
Agios Announces FDA Approval of Tibsovo as Monotherapy for Newly Diagnosed Adult Patients with IDH1 Mutant Acute Myeloid Leukemia (AML) Not Eligible for Intensive Chemotherapy
›
Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, announced th...
›
Home
View web version
